Cysticlean 118mg PACWhat is the proof?
Studies on Cranberry
Studies identifying that the preventative action of cranberry is directly related to the level of PAC
Studies Using Cysticlean
1. Preclinical and clinical studies demonstrated that Cysticlean has an anti-adhesive effect on E coli on the inner bladder wall of up to 83%. This is the key factor for assessing the performance of cranberry extract supplements. Our data on file indicates that the level of cranberry extract alone is not the only indicator affecting the effectiveness in preventing urinary low tract infections but more importantly the level of PAC Type A

Sources
* EFFECT OF CRANBERRY (CYSTICLEAN) ON THE ADHERENCE CAPACITY OF ESCHERICHIA COLI TO EPITHELIAL CELLS OF THE URINARY INNER BLADDER WALL. AN IN VITRO AND EX VIVO STUDY, Arch. Esp. Urol. 2010; 63 (6), Ester Risco, Carlos Miguelez, Eduardo Sanchez de Badajoz y Alberto Rouseaud.
* IN VITRO EVALUATION STUDY OF E. COLI ADHESION TO T24 CELLS, Harlan Laboratories Study S24908
* IN VITRO EVALUATION STUDY OF E. COLI ADHESION TO T24 CELLS, Harlan Laboratories Study S25516
2. Several human observational studies with Cysticlean, with over 500 women participating has indicated up to 80% reduction in the number of urinary infections experienced, with no side effects. Details below:
| 1 tablet/sachet a day ingested in the evening of CysticleanR with 118 mg of PAC is giving the maximum protection to prevent the recurrence of urinary tract infections. Patients have experienced a significant reduction of new urinary infection episodes compared to their previous experience. All patients evaluated were suffering from recurrent urinary tract infections every year > 3 episodes per year |
3. Currently there is a trial running with 500 patients, living in a nursing home who are 65 years of age and older. It is a double blind, placebo controlled trial with continuous treatment using Cysticlean over a period of 6 months .The trial is to evaluate if the recurrence of urinary infections decreases with the continuous use of Cysticlean. This is the first study involving the largest number of elderly patients to demonstrate the effect of Cranberry on urinary tract infection. The study started late 2010 and more than 150 patients are already under treatment. This study will help to confirm the use of Cystilcean in these patients, helping them to reduce their urinary infections and reducing the consumption of antibiotics needed to treat this disease.
Other Facts about Cysticlean